130 results
Page 5 of 7
6-K
EX-99.1
0mo3xqctj
3 Feb 22
Biophytis received approval from ANVISA (Brazil) to give
11:43am
6-K
EX-99.1
72n2am20
23 Dec 21
Biophytis announces the drawing of the last tranche of ORNANE under the 2020 Atlas Contract for €3 million
10:41am
6-K
EX-99.1
9coqzi0
17 Dec 21
Biophytis to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from Phase 2 to Phase 3
10:39am
6-K
EX-99.1
qc20m
23 Nov 21
Current report (foreign)
12:46pm
6-K
EX-99.1
v90jkztxoz710oor0
15 Nov 21
Biophytis announces US centers to restart recruitment for the COVA phase 2-3 study with Sarconeos (BIO101) in COVID-19
10:36am
6-K
EX-99.1
hwclmfysgtxmcd00kf1v
29 Oct 21
Current report (foreign)
7:58am
20-F/A
p0nr290xje5xkkwd
28 Oct 21
Annual report (foreign) (amended)
5:16pm
6-K
EX-99.1
frh6r5 dp9iz0
7 Oct 21
Biophytis to Restate Previously Issued Financial Statements
6:05am
6-K
EX-99.1
xd1e3ezolub6k dkecb
6 Oct 21
Current report (foreign)
11:52am
6-K
EX-99.1
zn68ne8gpdsmqht 8sp
6 Oct 21
Biophytis announces the drawing of 2 new tranches of ORNANE under the 2020 Atlas Contract for €6 million
9:46am
6-K
EX-99.1
itt4qoj0
4 Oct 21
Current report (foreign)
11:45am
6-K
EX-99.1
1ygo74mk16h
29 Sep 21
Biophytis to Present Full Results from the SARA-INT Phase
11:44am
6-K
EX-99.1
c5ejnrsn nmxd
17 Sep 21
Biophytis reports H1 2021 financial results and provides business update
11:05am
6-K
EX-99.1
q2xcd4365zrah2 y8hzf
15 Sep 21
Current report (foreign)
1:59pm
6-K
EX-99.1
zy0qd
17 Aug 21
Current report (foreign)
9:46am
6-K
EX-99.1
4qdfrnko7fhne4k
16 Aug 21
Current report (foreign)
7:48am
6-K
EX-99.1
4le i7wft675fzr
2 Aug 21
Biophytis Announces Top Line Results of Sara-int Phase 2 Study with Sarconeos (BIO101) In Sarcopenia
8:08am
6-K
EX-99.1
kgy 5y3ck52
20 Jul 21
Current report (foreign)
8:41am
6-K
EX-99.1
ndc 4847dnxpe
8 Jul 21
Biophytis Reinforces Leadership Teams with Three Senior Appointments
6:04am
6-K
EX-99.1
j1dajh nii66k52
1 Jul 21
Current report (foreign)
6:31am